Blastomycosis in solid organ transplant recipients

Transplant Infectious Disease

Volumn 9, Issue 4, 2007, Pages 310-317

  Gauthier, G M ^a   Safdar, N ^a   Klein, B S ^b   Andes, D R ^a  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Acute respiratory distress syndrome; Blastomycosis; Transplantation

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ITRACONAZOLE; VORICONAZOLE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; HUMAN; IMMUNE DEFICIENCY; MALE; MORTALITY; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; PNEUMONIA; PRIORITY JOURNAL;

ADULT; AGED; BLASTOMYCES; BLASTOMYCOSIS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PNEUMONIA; RESPIRATORY DISTRESS SYNDROME, ADULT; WISCONSIN;

EID: 35848961215     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2007.00227.x     Document Type: Article

References (49)

1. Anonymous. Blastomycosis - Wisconsin, 1986-1995. MMWR Morb Mortal Wkly Rep 1996 45 : 601 603.
2. Furcolow ML, Busey JF, Menges RW, Chick EW. Prevalence and incidence studies of human and canine blastomycosis. II. Yearly incidence studies in three selected states 1960-1967. Am J Epidemiol 1970 92 : 121 131.
3. Klein BS, Davis JP. A laboratory-based surveillance of human blastomycosis in Wisconsin between 1973 and 1982. Am J Epidemiol 1985 122 : 897 903.
4. Drutz DJ, Frey CL. Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts. J Lab Clin Med 1985 105 : 737 750.
5. Romani L. Immunity to fungal infections. Nat Rev Immunol 2004 4 : 1 13.
6. Wuthrich M, Filutowicz HI, Warner T, Deepe GS Jr., Klein BS. Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J Exp Med 2003 197 : 1405 1416.
7. Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am 2003 17 : 113 134.
8. Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 2001 33 : 1536 1544.
9. Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioidomycosis in renal replacement therapy. Arch Intern Med 1982 142 : 489 494.
10. Davies SF, Khan M, Sarosi GA. Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a nonendemic area. Am J Med 1978 64 : 94 100.
11. Peddi VR, Hariharan S, First MR. Disseminated histoplasmosis in renal allograft recipients. Clin Transplant 1996 10 : 160 165.
12. Wheat LJ, Smith EJ, Sathapatayavongs B, et al. Histoplasmosis in renal allograft recipients. Two large urban outbreaks. Arch Intern Med 1983 143 : 703 707.
13. Pappas PG, Threlkeld MG, Bedsole GD, Cleveland KO, Gelfand MS, Dismukes WE. Blastomycosis in immunocompromised patients. Medicine 1993 72 : 311 325.
14. Butka BJ, Bennett SR, Johnson AC. Disseminated inoculation blastomycosis in a renal transplant recipient. Am Rev Respir Dis 1984 130 : 1180 1183.
15. Green NB, Baughman RP, Kim CK, Roselle GA. Failure of ketoconazole in an immunosuppressed patient with pulmonary blastomycosis. Chest 1985 88 : 640 641.
16. Hii JH, Legault L, DeVeber G, Vas SI. Successful treatment of systemic blastomcyosis with high-dose ketoconazole in a renal transplant recipient. Am J Kidney Dis 1990 15 : 595 597.
17. Linden P, Williams P, Chan KM. Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections. Clin Transplant 2000 14 : 329 339.
18. Pechan WB, Novick AC, Lalli A, Gephardt G. Pulmonary nodules in a renal transplant recipient. J Urol 1980 124 : 111 114.
19. Serody JS, Mill MR, Detterbeck FC, Harris DT, Cohen MS. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis 1992 16 : 54 58.
20. Walker K, Skelton H, Smith K. Cutaneous lesions showing giant yeast forms of Blastomyces dermatitidis. J Cutan Pathol 2002 29 : 616 618.
21. Winkler S, Stanek G, Hubsch P, et al. Pneumonia due to Blastomcyes dermatitidis in a European renal transplant recipient. Nephrol Dial Transplant 1996 11 : 1376 1379.
22. Zampogna JC, Hoy MJ, Ramos-Caro FA. Primary cutaneous North American blastomycosis in an immunosuppressed child. Pediatr Dermatol 2003 20 : 128 130.
23. Klein BS, Vegeront JM, Kaufman L, et al. Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin. J Infect Dis 1987 155 : 262 268.
24. Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994 149 : 818 824.
25. Frampton JE, Wagstaff AJ. Alemtuzumab. Drugs 2003 63 : 1229 1243.
26. Deresinski SC, Stevens DA. Coccidioidomycosis in compromised hosts. Experience at Stanford University Hospital. Medicine 1975 54 : 377 395.
27. Hall KA, Sethi GK, Rosado LJ, Martinez JD, Huston CL, Copeland JG. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant 1993 12 : 525 526.
28. Holt CD, Winston DJ, Kubak B, et al. Coccidioidomycosis in liver transplant patients. Clin Infect Dis 1997 24 : 216 221.
29. Miller MB, Hendren R, Gilligan PH. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol 2004 42 : 2347 2349.
30. Tripathy U, Yung GL, Kriett JM, Thistlethwaite PA, Kapelanski DP, Jamieson SW. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg 2002 73 : 306 308.
31. Wright PW, Pappagianis D, Wilson M, et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 2003 37 : 1265 1269.
32. Nakelchik M, Magino JE. Reactivation of histoplasmosis after treatment with infliximab. Am J Med 2002 112 : 78.
33. Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 2003 3 : 578 590.
34. Barshes NR, Goodpastor SE, Goss JA. Pharmacologic immunosuppression. Front Biosci 2004 9 : 411 420.
35. Hildner K, Marker-Hermann E, Schlaak JF, et al. Azathioprine, mycophenolate mofetil, and methotrexate specifically modulate cytokine production by T cells. Ann N Y Acad Sci 1998 859 : 204 207.
36. Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med 2004 351 : 2715 2729.
37. Brummer E, Morrison CJ, Stevens DA. Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect Immun 1985 49 : 724 730.
38. Morrison CJ, Brummer E, Stevens DA. In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing. Infect Immun 1989 57 : 2953 2958.
39. Van Rijen MM, Metselaar HJ, Hommes M, Ijzermans JN, Tilanus HW, Kwekkeboom J. Mycophenolic acid is a potent inhibitor of the expression of tumour necrosis factor- and tumour necrosis factor-receptor superfamily costimulatory molecules. Immunology 2003 109 : 109 116.
40. Lemos LB, Baliga M, Buo M. Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature. Ann Diagn Pathol 2001 5 : 1 9.
41. Vasquez JE, Mehta JB, Agrawal R, Sarubbi FA. Blastomycosis in northeast Tennessee. Chest 1998 114 : 436 443.
42. Pappas PG, Pottage JC, Powderly WG, et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992 116 : 847 853.
43. Klein BS, Vergeront JM, DiSalvo AF, Kaufman L, Davis JP. Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways. Am Rev Respir Dis 1987 136 : 1333 1338.
44. Smith JG, Harris JS, Conant NF. An epidemic of North American blastomycosis. JAMA 1955 158 : 641 645.
45. Chapman SW, Rogers PD, Rinaldi MG, Sullivan DC. Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole. Antimicrob Agents Chemother 1998 42 : 978 980.
46. Espinel-Ingroff A. In vitro activity of the new triazole voriconazole (UK-109, 496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol 1998 36 : 198 202.
47. Li RK, Ciblak MA, Nordoff N, Pasarell L, Warnock DW, McGinnis MR. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother 2000 44 : 1734 1736.
48. Tucker RM, Hanson LH, Brummer E, Stevens DA. Activity of ICI 195,739, a new oral triazole, compared with that of ketoconazole in the therapy of experimental murine blastomycosis. Antimicrob Agents Chemother 1989 33 : 573 575.
49. Chapman SW. Blastomyces dermatitidis. In : Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia, PA : Elsevier Churchill Livingston, 2005 : 3026 3037.